Pintova, S., Dharmupari, S., Moshier, E., Zubizarreta, N., Ang, C., & Holcombe, R. F. (2019). Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: Phase I/II pilot study. Cancer chemotherapy and pharmacology, 84(3), 591-598. https://doi.org/10.1007/s00280-019-03886-3
Citace podle Chicago (17th ed.)Pintova, Sofya, Sirish Dharmupari, Erin Moshier, Nicole Zubizarreta, Celina Ang, a Randall F. Holcombe. "Genistein Combined with FOLFOX or FOLFOX–Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study." Cancer Chemotherapy and Pharmacology 84, no. 3 (2019): 591-598. https://doi.org/10.1007/s00280-019-03886-3.
Citace podle MLA (9th ed.)Pintova, Sofya, et al. "Genistein Combined with FOLFOX or FOLFOX–Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study." Cancer Chemotherapy and Pharmacology, vol. 84, no. 3, 2019, pp. 591-598, https://doi.org/10.1007/s00280-019-03886-3.